Oxidative Phosphorylation Dysfunction Modifies the Cell Secretome
Autor: | Ana Vela-Sebastián, Sonia Emperador, Ester López-Gallardo, Patricia Meade, Cecilia Jimenez-Mallebrera, Eduardo Ruiz-Pesini, Nuria Garrido-Pérez, Eldris Iglesias, M. Pilar Bayona-Bafaluy, Julio Montoya |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Vascular Endothelial Growth Factor A
Mitochondrial DNA Growth Differentiation Factor 15 FGF21 interleukine-6 Cell fibroblast growth factor 21 Review Oxidative phosphorylation mitochondrial DNA Biology DNA Mitochondrial Oxidative Phosphorylation Catalysis Inorganic Chemistry lcsh:Chemistry chemistry.chemical_compound medicine Humans oxidative phosphorylation system Genetic variability Physical and Theoretical Chemistry Molecular Biology lcsh:QH301-705.5 Spectroscopy mitochondrial diseases Secretory Pathway vascular endothelial growth factor Interleukin-6 Organic Chemistry biomarkers General Medicine Computer Science Applications Cell biology Fibroblast Growth Factors Vascular endothelial growth factor Circulating biomarkers secretome medicine.anatomical_structure chemistry lcsh:Biology (General) lcsh:QD1-999 GDF15 |
Zdroj: | International Journal of Molecular Sciences, Vol 21, Iss 3374, p 3374 (2020) International Journal of Molecular Sciences |
ISSN: | 1661-6596 1422-0067 |
Popis: | Mitochondrial oxidative phosphorylation disorders are extremely heterogeneous conditions. Their clinical and genetic variability makes the identification of reliable and specific biomarkers very challenging. Until now, only a few studies have focused on the effect of a defective oxidative phosphorylation functioning on the cell’s secretome, although it could be a promising approach for the identification and pre-selection of potential circulating biomarkers for mitochondrial diseases. Here, we review the insights obtained from secretome studies with regard to oxidative phosphorylation dysfunction, and the biomarkers that appear, so far, to be promising to identify mitochondrial diseases. We propose two new biomarkers to be taken into account in future diagnostic trials. |
Databáze: | OpenAIRE |
Externí odkaz: |